Telephone Versus In-person Post-test Cancer Genetic Counseling
NCT ID: NCT04759352
Last Updated: 2021-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
724 participants
INTERVENTIONAL
2021-05-15
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Strategies to Communicate Genetic Information to Different Ethnic Subpopulations
NCT03023735
Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling
NCT05132868
Use of Videos to Improve Patient Knowledge on Prenatal Genetics
NCT03816423
Posting of Basic Results of Clinical Trials
NCT01658254
Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients
NCT02645357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is open label; thus, patients and investigators will not be blinded to treatment allocation due to the study nature intervention.
After randomization, participants will be scheduled for post-test genetic counseling session. Participants randomized to usual care will receive standard in-person result disclosure. Participants randomized to telephone counseling will be scheduled for telephone post-test counseling sessions. One-week after completing the post-test genetic counseling session, the survey package will be sent by email to participants to assess impact and satisfaction with post-test counseling.
Genetic counselors delivering post-test genetic counseling will complete the questionnaire immediately after the post-test session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telephone post-test genetic counseling
Post-test genetic counseling delivered by telephone
Post-test genetic counseling delivered by telephone
Participants enrolled in the experimental arm will receive genetic counseling for test result communication by telephone.
In-person post-test genetic counseling
Post-test genetic counseling delivered in-person
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Post-test genetic counseling delivered by telephone
Participants enrolled in the experimental arm will receive genetic counseling for test result communication by telephone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must have undergone an in-person pre-test genetic counseling session;
* Patients must have undertaken cancer genetic testing;
* Patients must be able to speak Italian fluently;
* Patients must have got an email address.
Exclusion Criteria
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniela Turchetti
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UO Genetica Medica, IRCCS AOU di Bologna
Bologna, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GEO-STAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.